News
Dr. Gillian Cannon Joins Lindus Therapeutics’ Board as a Non-Executive Director
Lindus Therapeutics, a next-generation drug development company advancing a portfolio of in-licensed assets, has announced the appointment of Dr. Gillian Cannon to its board of directors as a non-executive director.
.jpeg)
Why working with a university isn't always best for DTx start-ups
Our Co-Founder Michael explores the best options for DTx startups looking to start generating clinical evidence and why it might not always be best to work with academic institutions.
Why I Joined Lindus Health - Emma Ogburn PhD, VP Clinical Operations
To work on innovative trials and accelerate access to treatments. To tackle disparities in research accessibility. To use technology to accelerate studies and work with a motivated team. Hear more from our VP of Clinical Operations, Emma Ogburn PhD, on why she joined Lindus Health.
Lindus Health and Thirty Madison complete enrollment of personalized dermatology care pilot study
We're excited to announce the completion of enrollment in Thirty Madison's personalized dermatology care pilot study that we're delivering.
Product Clinic #9: Bringing about the right kind of change with AI
Amiel Kollek, senior software engineer at Lindus Health, reflects on the use of AI in clinical trials and how it can be used to bring about the right kind of change.
Drug Discovery is Becoming More $$$ — Here's Why, And How We're Fixing IT
Drug discovery is becoming more expensive and producing less results than ever before (Eroom's Law) —why? One of the ballooning costs is clinical trials. Our co-founder Meri Beckwith sits down with Dr. Mustafa Sultan, creator of The Big Picture Medicine Podcast, to talk through how we're building the anti-CRO (Lindus Health!) to solve this problem.
Discussing the FDA’s latest draft guidances on 510k submissions with M. Jason Brooke, Managing Member at Brooke & Associates
M. Jason Brooke, Attorney and Managing Member at Brooke & Associates, was kind enough to stop by our virtual fireplace to discuss the FDA’s latest draft guidances on 510k submissions and share tips on how medical device companies could best navigate them.
Clinical trial launches to develop Diagnostic Tampon for at-home HPV and STI testing
We're excited to announce that we've launched a clinical study with Daye, a UK-based gynaecological health startup, to develop a Diagnostic Tampon for at-home HPV and STI testing.
Lindus Health and Oto launch remote trial to combat tinnitus
We're excited to announce that we've launched a fully remote clinical study with Oto, a UK-based digital health startup, to combat tinnitus.
Announcing our $18m Series A led by investors Creandum and with participation from Peter Thiel
The funding comes from Spotify-backer Creandum, with participation from PayPal co-founder Peter Thiel and returning investors firstminute, Seedcamp, Hambro Perks, Amino Collective, Page One Ventures and Calm/Storm. Additional investment has been provided by angel investors including Nadav Rosenberg, Kaysan Nikkhah, Trevor Martin, Soraya Darabi, Andrej Steinberg, Tom Krüger and Mithi Thaya.
Why I joined Lindus Health - Anthony Brogno, Director of Clinical Operations
To break the mold of the CRO status quo. To leverage social medial and technology to support research operations. The Lindus Health culture. Hear more from Anthony Brogno, Director of Clinical Operations, on why he joined Lindus Health.